bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.04.11.487903

Neural mass modelling for the masses: Democratising access to whole-brain biophysical modelling with FastDMF

Abstract

Different whole-brain models constrained by neuroimaging data have been developed during the last years to investigate causal hypotheses related to brain mechanisms. Among these, the Dynamic Mean Field (DMF) model is a particularly attractive model, combining a biophysically realistic single-neuron model that is scaled up via a mean-field approach and multimodal imaging data. Despite these favourable features, an important barrier for a widespread usage of the DMF model is that current implementations are computationally expensive - to the extent that the model often becomes unfeasible when no high-performance computing infrastructure is available. Furthermore, even when such computing structure is available, current implementations can only support simulations on brain parcellations that consider less than 100 brain regions. To remove these barriers, here we introduce a user-friendly and computationally-efficient implementation of the DMF model, which we call FastDMF, with the goal of making biophysical whole-brain modelling accessible to neuroscientists worldwide. By leveraging a suit of analytical and numerical advances - including a novel estimation of the feedback inhibition control parameter, and a Bayesian optimisation algorithm - the FastDMF circumvents various computational bottlenecks of previous implementations. An evaluation of the performance of the FastDMF showed that it can attain a significantly faster performance than previous implementations while reducing the memory consumption by several orders of magnitude. Thanks to these computational advances, FastDMF makes it possible to increase the number of simulated regions by one order of magnitude: we found good agreement between empirical and simulated functional MRI data parcellated at two different spatial scales (N=90 and N=1000 brain regions). These advances open the way to the widespread use of biophysically grounded whole-brain models for understanding the interplay among anatomy, function and brain dynamics in health and disease, and to provide mechanistic explanations of recent results obtained from empirical fine-grained neuroimaging data sets, such as turbulence or connectome harmonics. HighlightsO_LIWe present the FastDMF, a user-friendly and computationally efficient implementation of the Dynamic Mean Field model for simulations of whole-brain dynamics. C_LIO_LIUsing analytical and numerical tools, we develop a novel estimation of the feedback inhibition control based on the structural connectivity, bypassing an important computational bottleneck. C_LIO_LIThe FastDMF is coupled with a Bayesian Optimization algorithm significantly reducing the number of simulations required to fit the FastDMF to empirical neuroimaging data. C_LIO_LIOur advances open the possibility of simulating thousands of brain regions in a biophysically grounded whole-brain model. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Herzog, R., Mediano, P., Rosas, F. E., Luppi, A. I., Perl, Y. S., Tagliazucchi, E., Kringelbach, M. L., Cofre, R., Deco, G.. 2022-04-11. Neural mass modelling for the masses: Democratising access to whole-brain biophysical modelling with FastDMF. https://doi.org/10.1101/2022.04.11.487903

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗